Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Company
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:

- Collaboration revenue (79.8%);

- Grant revenue (20.2%).

At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and three in phase I.

Number of employees : 1 300 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Transformative Medicines60.21100%803.40100% +1234.34%
Sales per region
2020
USD (in Million)%
United States764.5395.2%
Rest of World38.874.8%
Managers
NameAgeSinceTitle
Stéphane Bancel472011Chief Executive Officer & Director
Stephen Hoge442015President
David Meline622020Chief Financial Officer
Juan Andres552017Chief Technical Operations & Quality Officer
Tal Zaks542015Chief Medical Officer
Paul Sagan612018Independent Non-Executive Director
Robert Langer712010Independent Non-Executive Director
Stephen A. Berenson592017Independent Non-Executive Director
Noubar Afeyan572012Chairman
Francois Nader632019Independent Non-Executive Director
Members of the board
NameAgeSinceTitle
Noubar Afeyan572012Chairman
Paul Sagan612018Independent Non-Executive Director
Robert Langer712010Independent Non-Executive Director
Stephen A. Berenson592017Independent Non-Executive Director
Stéphane Bancel472011Chief Executive Officer & Director
Francois Nader632019Independent Non-Executive Director
Sandra J. Horning, Dr.712020Independent Director
Elizabeth E. Tallett702020Independent Director
Elizabeth G. Nabel, Dr.682021Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 401,527,789 362,619,946 90.3% 0 0.0% 90.3%
Shareholders
NameEquities%
Baillie Gifford & Co. 45,337,764 11.3%
Stéphane Bancel 22,715,594 5.66%
Flagship Pioneering 20,581,016 5.13%
The Vanguard Group, Inc. 18,204,552 4.53%
Robert Langer 11,509,357 2.87%
BlackRock Fund Advisors 7,598,007 1.89%
Thélème Partners LLP 6,302,056 1.57%
SSgA Funds Management, Inc. 6,008,874 1.50%
Fidelity Management & Research Co. LLC 5,550,272 1.38%
Morgan Stanley Investment Management, Inc. 3,910,621 0.97%
Markets and indexes
-
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  MRNA.O
- Datastream Code :  
Company contact information
Moderna, Inc.
200 Square Technology
MA 02139 Cambridge, Massachusetts


Phone : +1 617 714 6500
Fax : +1 617 583 1998
web site : https://www.modernatx.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Moderna, Inc.
Sector Other Biotechnology & Medical Research
1st jan.Capitalization (M$)
MODERNA, INC.98.54%83 281
LONZA GROUP AG16.84%54 908
IQVIA HOLDINGS INC.36.45%46 855
CELLTRION, INC.-21.73%34 341
SEAGEN INC.-10.76%28 363
HANGZHOU TIGERMED CONSULTING CO., LTD13.85%24 129
PHARMARON BEIJING CO., LTD.64.77%23 715
CUREVAC N.V.22.12%21 497
ALNYLAM PHARMACEUTICALS, INC.28.23%19 590
INCYTE CORPORATION-5.06%18 174
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.40.91%17 856
BIO-TECHNE CORPORATION41.51%17 477
PPD, INC.35.97%16 341
NOVAVAX, INC.86.27%15 385
ICON PUBLIC LIMITED COMPANY10.18%11 356
PRA HEALTH SCIENCES, INC.34.01%10 892
QIAGEN N.V.-10.27%10 831
CRISPR THERAPEUTICS AG-15.90%9 756
GENSCRIPT BIOTECH CORPORATION189.01%8 680
SYNEOS HEALTH, INC.22.52%8 625
BACHEM HOLDING AG35.02%8 313